Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912282-25-000788
Filing Date
2025-07-22
Accepted
2025-07-22 13:32:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6117
2 JOINT FILING AGREEMENT jointfilingagmt.htm EX-1.01 7147
  Complete submission text file 0000912282-25-000788.txt   15183
Mailing Address C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108 416-408-0997
MMCAP International Inc. SPC (Filed by) CIK: 0001304857 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Subject) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93404 | Film No.: 251139654
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)